Lower riskDrug recall · FDA · Published November 26, 2025
Golden State Baclofen Tablets Recall: Foreign Tablets Risk
Golden State Medical Supply recalls 10mg Baclofen tablets due to foreign tablets present. This prescription medication may cause harm if used without proper verification.
“Golden State Baclofen Tablets Recall: Foreign Tablets Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/31624-golden-state-baclofen-tablets-recall-foreign-tablets-risk. Based on FDA recall #D-0235-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0235-2026%22&limit=1).
The FDA announced on November 26, 2025, that Golden State Medical Supply Inc. is recalling Baclofen Tablets USP, 10 mg, due to the presence of foreign tablets or capsules. The firm initiated this voluntary Class II recall affecting 2,472 bottles distributed nationwide.
How to tell if you have it
Brand: Golden State Medical Supply
Product: Baclofen Tablets USP, 10 mg
Packaging: 1000-count HDPE Bottles
NDC: 51407-973-10
Lot Code: GS065762
Quantity: 2,472 bottles
The hazard
The recall addresses the presence of foreign tablets or capsules within the Baclofen product. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Golden State Medical Supply Inc. has 31 other recalls on record since April 14, 2014. Other recent recalls of similar products include Graviti Furosemide Tablets Recall (January 10, 2026), Bionpharma Divalproex Tablets Recall (June 26, 2026), and Amgen Recalls Corlanor 5mg Tablets Due to Foreign Substance (June 4, 2026).
How to tell if you have this one
Check for the product name 'Baclofen Tablets USP, 10 mg, 1000-count bottles' with NDC 51407-973-10 and lot number GS065762. This medication is prescription-only and sold by Golden State Medical Supply.
Brand
Golden State Medical Supply
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the product name, NDC number 51407-973-10, and lot number GS065762 to confirm if it's recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 28 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0235-2026 (November 26, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0235-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.